Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSMUSG00000038482.10 | transcription factor Dp 1 |
Wt1
|
ENSMUSG00000016458.7 | Wilms tumor 1 homolog |
Egr2
|
ENSMUSG00000037868.9 | early growth response 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_67537369_67537539 | Egr2 | 415 | 0.780524 | 0.89 | 1.8e-02 | Click! |
chr10_67537712_67537872 | Egr2 | 77 | 0.959097 | 0.83 | 4.3e-02 | Click! |
chr10_67536130_67536293 | Egr2 | 628 | 0.636590 | 0.79 | 6.0e-02 | Click! |
chr10_67536858_67537009 | Egr2 | 936 | 0.470676 | 0.78 | 7.0e-02 | Click! |
chr10_67537122_67537295 | Egr2 | 661 | 0.614620 | 0.51 | 3.0e-01 | Click! |
chr8_13338548_13338711 | Tfdp1 | 122 | 0.940245 | 0.88 | 2.0e-02 | Click! |
chr8_13365227_13365425 | Tfdp1 | 156 | 0.928346 | -0.81 | 5.0e-02 | Click! |
chr8_13338270_13338453 | Tfdp1 | 390 | 0.776178 | -0.68 | 1.3e-01 | Click! |
chr8_13364807_13364958 | Tfdp1 | 288 | 0.853658 | -0.62 | 1.9e-01 | Click! |
chr8_13353983_13354151 | Tfdp1 | 11103 | 0.117750 | 0.56 | 2.5e-01 | Click! |
chr2_105189446_105189605 | Wt1 | 26717 | 0.167309 | -0.09 | 8.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_29093649_29093812 | 8.36 |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
39 |
0.91 |
chr8_94172420_94173095 | 8.35 |
Mt2 |
metallothionein 2 |
93 |
0.88 |
chr2_68873804_68874167 | 7.63 |
Cers6 |
ceramide synthase 6 |
12399 |
0.14 |
chr12_28886991_28887442 | 7.59 |
Gm48080 |
predicted gene, 48080 |
834 |
0.6 |
chr11_115535817_115535982 | 7.31 |
Sumo2 |
small ubiquitin-like modifier 2 |
82 |
0.94 |
chr10_80139371_80139556 | 7.21 |
Cbarp |
calcium channel, voltage-dependent, beta subunit associated regulatory protein |
98 |
0.88 |
chr16_43979496_43979654 | 6.78 |
Zdhhc23 |
zinc finger, DHHC domain containing 23 |
216 |
0.92 |
chr17_27557519_27557704 | 6.77 |
Hmga1 |
high mobility group AT-hook 1 |
916 |
0.28 |
chr12_76710114_76710283 | 6.74 |
Sptb |
spectrin beta, erythrocytic |
175 |
0.95 |
chr1_133908470_133908621 | 6.64 |
Optc |
opticin |
546 |
0.66 |
chr1_191718324_191718483 | 6.53 |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
14 |
0.98 |
chr19_42612808_42613017 | 6.45 |
Loxl4 |
lysyl oxidase-like 4 |
99 |
0.97 |
chr5_75044529_75044680 | 6.43 |
Chic2 |
cysteine-rich hydrophobic domain 2 |
170 |
0.92 |
chr1_39193049_39193247 | 6.41 |
Npas2 |
neuronal PAS domain protein 2 |
583 |
0.75 |
chr4_151044647_151045045 | 6.23 |
Per3 |
period circadian clock 3 |
181 |
0.94 |
chr10_75044491_75044663 | 6.11 |
Rab36 |
RAB36, member RAS oncogene family |
6354 |
0.16 |
chr9_21032221_21032372 | 5.83 |
Mir1900 |
microRNA 1900 |
32 |
0.44 |
chr19_36409926_36410077 | 5.79 |
Pcgf5 |
polycomb group ring finger 5 |
253 |
0.9 |
chr11_102296592_102296743 | 5.75 |
Atxn7l3 |
ataxin 7-like 3 |
36 |
0.95 |
chr13_74121256_74121414 | 5.52 |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
122 |
0.96 |
chr15_77150122_77150279 | 5.47 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3356 |
0.18 |
chr2_94273299_94273450 | 5.46 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8456 |
0.15 |
chr9_63698782_63698955 | 5.27 |
Smad3 |
SMAD family member 3 |
13101 |
0.22 |
chr17_46030522_46030717 | 5.22 |
Vegfa |
vascular endothelial growth factor A |
737 |
0.63 |
chr17_5841238_5841411 | 5.22 |
Snx9 |
sorting nexin 9 |
5 |
0.97 |
chr7_104502188_104502379 | 5.17 |
Gm16464 |
predicted gene 16464 |
134 |
0.91 |
chr18_35887757_35887908 | 5.14 |
Gm36315 |
predicted gene, 36315 |
2505 |
0.16 |
chr5_44226591_44226765 | 4.86 |
Tapt1 |
transmembrane anterior posterior transformation 1 |
52 |
0.54 |
chr11_49088297_49088883 | 4.85 |
Gm12188 |
predicted gene 12188 |
47 |
0.79 |
chr8_94666713_94666864 | 4.85 |
Arl2bp |
ADP-ribosylation factor-like 2 binding protein |
64 |
0.95 |
chr17_23675280_23675431 | 4.73 |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
1198 |
0.16 |
chr18_21299503_21299713 | 4.63 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
515 |
0.76 |
chr16_22163049_22163219 | 4.63 |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
115 |
0.96 |
chr11_86993752_86993946 | 4.63 |
Ypel2 |
yippee like 2 |
142 |
0.95 |
chr13_43481219_43481403 | 4.60 |
Ranbp9 |
RAN binding protein 9 |
29 |
0.97 |
chr11_75444470_75444637 | 4.56 |
Serpinf2 |
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
4962 |
0.09 |
chr7_12928134_12928293 | 4.55 |
Rnf225 |
ring finger protein 225 |
797 |
0.37 |
chr8_120634223_120634454 | 4.47 |
1190005I06Rik |
RIKEN cDNA 1190005I06 gene |
25 |
0.95 |
chrX_142966834_142966985 | 4.47 |
Ammecr1 |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
181 |
0.96 |
chr5_137741641_137741817 | 4.40 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
122 |
0.92 |
chr4_148900818_148900969 | 4.38 |
Casz1 |
castor zinc finger 1 |
256 |
0.91 |
chr1_39194066_39194239 | 4.36 |
Npas2 |
neuronal PAS domain protein 2 |
60 |
0.97 |
chr3_127895575_127896072 | 4.34 |
Fam241a |
family with sequence similarity 241, member A |
465 |
0.74 |
chr18_84088030_84088239 | 4.34 |
Zadh2 |
zinc binding alcohol dehydrogenase, domain containing 2 |
71 |
0.86 |
chr13_111809159_111809796 | 4.30 |
Gm15327 |
predicted gene 15327 |
336 |
0.59 |
chr8_119445523_119446899 | 4.30 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
508 |
0.74 |
chr11_97138815_97139024 | 4.28 |
Mir7235 |
microRNA 7235 |
7500 |
0.09 |
chr4_154160329_154160509 | 4.28 |
Tprgl |
transformation related protein 63 regulated like |
187 |
0.91 |
chr1_180813964_180814133 | 4.20 |
H3f3a |
H3.3 histone A |
105 |
0.7 |
chr19_4698221_4698442 | 4.20 |
Gm960 |
predicted gene 960 |
16 |
0.96 |
chr1_39192284_39192607 | 4.18 |
Npas2 |
neuronal PAS domain protein 2 |
1286 |
0.45 |
chr13_98594899_98595134 | 4.15 |
Gm4815 |
predicted gene 4815 |
18485 |
0.12 |
chr8_119444266_119444532 | 4.14 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
2320 |
0.23 |
chr4_43631313_43631464 | 4.12 |
Gm25262 |
predicted gene, 25262 |
37 |
0.87 |
chr8_11727709_11727902 | 4.12 |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF7) |
84 |
0.94 |
chr18_67933368_67933544 | 4.11 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
199 |
0.95 |
chr5_114564861_114565025 | 4.08 |
Fam222a |
family with sequence similarity 222, member A |
3073 |
0.22 |
chr4_148448716_148449227 | 4.05 |
Mtor |
mechanistic target of rapamycin kinase |
346 |
0.82 |
chr4_59189313_59189582 | 4.03 |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
111 |
0.96 |
chrX_12135564_12135758 | 4.03 |
Bcor |
BCL6 interacting corepressor |
7261 |
0.26 |
chr12_16895014_16895177 | 4.02 |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
72 |
0.97 |
chr1_69687475_69687652 | 4.02 |
Ikzf2 |
IKAROS family zinc finger 2 |
318 |
0.91 |
chr8_35587958_35588119 | 4.01 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
240 |
0.86 |
chr10_67127299_67127515 | 3.99 |
Jmjd1c |
jumonji domain containing 1C |
149 |
0.96 |
chr18_10934499_10934650 | 3.98 |
Gm7575 |
predicted gene 7575 |
5690 |
0.24 |
chr5_109558445_109558806 | 3.97 |
Crlf2 |
cytokine receptor-like factor 2 |
311 |
0.86 |
chr7_81706851_81707046 | 3.97 |
Homer2 |
homer scaffolding protein 2 |
4 |
0.97 |
chr16_78376213_78376364 | 3.92 |
Btg3 |
BTG anti-proliferation factor 3 |
522 |
0.76 |
chr1_52597910_52598075 | 3.90 |
Gm5527 |
predicted gene 5527 |
13474 |
0.13 |
chr8_33653901_33654202 | 3.88 |
Gsr |
glutathione reductase |
813 |
0.57 |
chr8_22398390_22398541 | 3.88 |
Slc25a15 |
solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 |
79 |
0.72 |
chr14_65358460_65358659 | 3.86 |
Zfp395 |
zinc finger protein 395 |
25 |
0.95 |
chr12_21111520_21111853 | 3.86 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
62 |
0.98 |
chr13_113035052_113035231 | 3.83 |
Cdc20b |
cell division cycle 20B |
30 |
0.91 |
chr8_126663289_126663717 | 3.82 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
69517 |
0.1 |
chr5_113908087_113908292 | 3.81 |
Coro1c |
coronin, actin binding protein 1C |
456 |
0.7 |
chr19_3850170_3850502 | 3.79 |
Chka |
choline kinase alpha |
1437 |
0.22 |
chr7_80402754_80402960 | 3.78 |
Furin |
furin (paired basic amino acid cleaving enzyme) |
95 |
0.93 |
chr17_29490659_29490810 | 3.76 |
Pim1 |
proviral integration site 1 |
19 |
0.88 |
chr5_36695522_36695787 | 3.73 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
283 |
0.87 |
chr12_102705049_102705200 | 3.72 |
Itpk1 |
inositol 1,3,4-triphosphate 5/6 kinase |
194 |
0.89 |
chr16_32246842_32247035 | 3.72 |
Fbxo45 |
F-box protein 45 |
220 |
0.55 |
chr12_19387644_19387817 | 3.72 |
Gm5784 |
predicted gene 5784 |
79 |
0.96 |
chr1_74124459_74124725 | 3.72 |
Tns1 |
tensin 1 |
143 |
0.91 |
chr4_8690229_8690380 | 3.72 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
102 |
0.98 |
chr19_3686522_3686708 | 3.72 |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
51 |
0.96 |
chr10_22173370_22173547 | 3.70 |
Raet1e |
retinoic acid early transcript 1E |
63 |
0.95 |
chr7_127708585_127708750 | 3.69 |
Bcl7c |
B cell CLL/lymphoma 7C |
28 |
0.67 |
chr14_47188148_47188661 | 3.67 |
Gch1 |
GTP cyclohydrolase 1 |
1009 |
0.36 |
chr19_46141233_46141384 | 3.66 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
325 |
0.82 |
chr2_167349082_167349264 | 3.66 |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
10 |
0.98 |
chr5_124354576_124354741 | 3.64 |
Cdk2ap1 |
CDK2 (cyclin-dependent kinase 2)-associated protein 1 |
13 |
0.96 |
chr13_41220523_41220693 | 3.62 |
Elovl2 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 |
203 |
0.91 |
chr12_84192763_84192978 | 3.62 |
Elmsan1 |
ELM2 and Myb/SANT-like domain containing 1 |
1145 |
0.32 |
chr5_122284523_122284674 | 3.61 |
Pptc7 |
PTC7 protein phosphatase homolog |
233 |
0.88 |
chr16_30070239_30070422 | 3.60 |
Hes1 |
hes family bHLH transcription factor 1 |
3992 |
0.18 |
chr8_84705414_84705592 | 3.59 |
Nfix |
nuclear factor I/X |
2213 |
0.16 |
chr5_122900348_122900511 | 3.59 |
Kdm2b |
lysine (K)-specific demethylase 2B |
74 |
0.96 |
chr13_47105847_47106030 | 3.58 |
Dek |
DEK oncogene (DNA binding) |
108 |
0.84 |
chr5_8997130_8997296 | 3.56 |
Gm37153 |
predicted gene, 37153 |
54 |
0.56 |
chr9_54501581_54501757 | 3.56 |
Dmxl2 |
Dmx-like 2 |
43 |
0.98 |
chr10_39731356_39731646 | 3.56 |
E130307A14Rik |
RIKEN cDNA E130307A14 gene |
275 |
0.72 |
chr2_90889702_90889896 | 3.55 |
Gm32514 |
predicted gene, 32514 |
3399 |
0.12 |
chr12_112976741_112977039 | 3.55 |
Btbd6 |
BTB (POZ) domain containing 6 |
56 |
0.94 |
chr5_33694927_33695093 | 3.54 |
Gm42965 |
predicted gene 42965 |
12036 |
0.1 |
chr16_28929709_28929875 | 3.54 |
Mb21d2 |
Mab-21 domain containing 2 |
119 |
0.98 |
chr7_44816552_44816741 | 3.53 |
Atf5 |
activating transcription factor 5 |
12 |
0.63 |
chr8_13338548_13338711 | 3.52 |
Tfdp1 |
transcription factor Dp 1 |
122 |
0.94 |
chr15_66968663_66969063 | 3.52 |
Gm2895 |
predicted gene 2895 |
460 |
0.61 |
chr11_109473196_109473409 | 3.50 |
Slc16a6 |
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
8 |
0.54 |
chr11_120348412_120348676 | 3.50 |
Actg1 |
actin, gamma, cytoplasmic 1 |
2 |
0.61 |
chr6_122339632_122339783 | 3.50 |
Phc1 |
polyhomeotic 1 |
1 |
0.97 |
chr2_153649547_153649762 | 3.48 |
Dnmt3b |
DNA methyltransferase 3B |
37 |
0.92 |
chr16_30257794_30257955 | 3.47 |
Gm49645 |
predicted gene, 49645 |
2722 |
0.2 |
chr18_75820116_75820288 | 3.47 |
Zbtb7c |
zinc finger and BTB domain containing 7C |
13 |
0.98 |
chr17_28298917_28299090 | 3.47 |
Ppard |
peroxisome proliferator activator receptor delta |
5757 |
0.11 |
chr11_59307084_59307285 | 3.46 |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
254 |
0.88 |
chr8_105518182_105518333 | 3.45 |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
498 |
0.63 |
chr10_22361736_22361909 | 3.45 |
Raet1d |
retinoic acid early transcript delta |
72 |
0.96 |
chr3_138742123_138742276 | 3.44 |
Tspan5 |
tetraspanin 5 |
4 |
0.98 |
chr18_53245549_53245731 | 3.44 |
Snx24 |
sorting nexing 24 |
22 |
0.98 |
chr13_98694658_98695181 | 3.42 |
Tmem171 |
transmembrane protein 171 |
85 |
0.96 |
chr8_119417171_119417322 | 3.42 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
16878 |
0.13 |
chr7_29309176_29309550 | 3.41 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
150 |
0.92 |
chr7_141068544_141068695 | 3.41 |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
1656 |
0.17 |
chr3_89391856_89392032 | 3.40 |
Gm15417 |
predicted gene 15417 |
26 |
0.6 |
chr4_133753668_133753824 | 3.38 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
135 |
0.95 |
chr11_80476708_80476917 | 3.37 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
211 |
0.94 |
chr6_72233913_72234064 | 3.37 |
Atoh8 |
atonal bHLH transcription factor 8 |
549 |
0.74 |
chr17_14992793_14992944 | 3.36 |
9030025P20Rik |
RIKEN cDNA 9030025P20 gene |
13369 |
0.1 |
chr7_105400022_105400305 | 3.36 |
Fam160a2 |
family with sequence similarity 160, member A2 |
109 |
0.54 |
chr5_120643893_120644074 | 3.34 |
Gm42657 |
predicted gene 42657 |
2362 |
0.13 |
chr15_39006188_39006363 | 3.34 |
Fzd6 |
frizzled class receptor 6 |
5 |
0.56 |
chr18_24205842_24206009 | 3.33 |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
34 |
0.98 |
chr1_36471443_36471653 | 3.32 |
Cnnm4 |
cyclin M4 |
72 |
0.94 |
chr10_61327652_61327821 | 3.32 |
Pald1 |
phosphatase domain containing, paladin 1 |
14591 |
0.12 |
chr4_59189104_59189276 | 3.30 |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
67 |
0.97 |
chr6_113991518_113991701 | 3.30 |
Gm15083 |
predicted gene 15083 |
13180 |
0.17 |
chr1_55363364_55363518 | 3.29 |
Boll |
boule homolog, RNA binding protein |
28 |
0.97 |
chr15_36472369_36472551 | 3.27 |
Ankrd46 |
ankyrin repeat domain 46 |
24255 |
0.12 |
chr8_85700892_85701043 | 3.26 |
Neto2 |
neuropilin (NRP) and tolloid (TLL)-like 2 |
43 |
0.51 |
chr6_38876253_38876417 | 3.26 |
Hipk2 |
homeodomain interacting protein kinase 2 |
170 |
0.91 |
chr17_80728037_80728199 | 3.25 |
Gm9959 |
predicted gene 9959 |
13 |
0.5 |
chr5_145114126_145114302 | 3.24 |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
1 |
0.95 |
chr16_95769794_95769976 | 3.24 |
Gm37259 |
predicted gene, 37259 |
10049 |
0.17 |
chr1_189727979_189728224 | 3.24 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
167 |
0.95 |
chr4_123412152_123412346 | 3.23 |
Macf1 |
microtubule-actin crosslinking factor 1 |
21 |
0.97 |
chr8_10899350_10899661 | 3.22 |
4833411C07Rik |
RIKEN cDNA 4833411C07 gene |
417 |
0.64 |
chr5_65764010_65764165 | 3.21 |
N4bp2 |
NEDD4 binding protein 2 |
33 |
0.73 |
chr11_120784479_120784636 | 3.21 |
Gps1 |
G protein pathway suppressor 1 |
42 |
0.81 |
chr10_77606135_77606289 | 3.20 |
Sumo3 |
small ubiquitin-like modifier 3 |
3 |
0.49 |
chr5_114560586_114560754 | 3.20 |
Fam222a |
family with sequence similarity 222, member A |
7346 |
0.16 |
chr10_61147562_61147732 | 3.20 |
Sgpl1 |
sphingosine phosphate lyase 1 |
3 |
0.97 |
chr2_121866807_121866994 | 3.19 |
Casc4 |
cancer susceptibility candidate 4 |
70 |
0.66 |
chr17_45595822_45596123 | 3.19 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
15 |
0.95 |
chr8_13200514_13200674 | 3.19 |
Grtp1 |
GH regulated TBC protein 1 |
7 |
0.61 |
chr4_139798704_139798855 | 3.18 |
Pax7 |
paired box 7 |
34228 |
0.17 |
chr14_103099200_103099351 | 3.17 |
Fbxl3 |
F-box and leucine-rich repeat protein 3 |
231 |
0.92 |
chr7_45866072_45866235 | 3.17 |
Grin2d |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) |
976 |
0.29 |
chr9_120731019_120731170 | 3.17 |
Gm47064 |
predicted gene, 47064 |
20049 |
0.12 |
chr11_115536197_115536563 | 3.16 |
Sumo2 |
small ubiquitin-like modifier 2 |
104 |
0.93 |
chr15_31531119_31531272 | 3.16 |
Marchf6 |
membrane associated ring-CH-type finger 6 |
142 |
0.94 |
chr4_41135837_41136046 | 3.15 |
Ube2r2 |
ubiquitin-conjugating enzyme E2R 2 |
198 |
0.88 |
chr8_94012655_94012827 | 3.15 |
Amfr |
autocrine motility factor receptor |
101 |
0.95 |
chr17_29094634_29094798 | 3.14 |
1700023B13Rik |
RIKEN cDNA 1700023B13 gene |
255 |
0.77 |
chr2_179442309_179442508 | 3.14 |
Cdh4 |
cadherin 4 |
23 |
0.98 |
chr1_39192739_39192927 | 3.13 |
Npas2 |
neuronal PAS domain protein 2 |
898 |
0.59 |
chr2_28513103_28513254 | 3.11 |
Ralgds |
ral guanine nucleotide dissociation stimulator |
53 |
0.95 |
chr11_120660498_120660709 | 3.11 |
Notum |
notum palmitoleoyl-protein carboxylesterase |
3 |
0.91 |
chr5_25498682_25498833 | 3.11 |
Kmt2c |
lysine (K)-specific methyltransferase 2C |
2 |
0.96 |
chr9_44721208_44721499 | 3.11 |
Phldb1 |
pleckstrin homology like domain, family B, member 1 |
34 |
0.94 |
chr2_179442637_179442918 | 3.10 |
Cdh4 |
cadherin 4 |
155 |
0.97 |
chr7_110614811_110614972 | 3.10 |
Sbf2 |
SET binding factor 2 |
5 |
0.97 |
chr11_80476990_80477175 | 3.09 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
26 |
0.98 |
chr16_21947505_21947687 | 3.08 |
Tmem41a |
transmembrane protein 41a |
44 |
0.97 |
chr2_161108266_161108515 | 3.07 |
Chd6 |
chromodomain helicase DNA binding protein 6 |
614 |
0.59 |
chr3_34019804_34019966 | 3.04 |
Gm43077 |
predicted gene 43077 |
3 |
0.53 |
chr17_50509012_50509163 | 3.04 |
Plcl2 |
phospholipase C-like 2 |
316 |
0.94 |
chr4_124700660_124700811 | 3.02 |
Fhl3 |
four and a half LIM domains 3 |
15 |
0.94 |
chr4_103119281_103119475 | 3.02 |
Mier1 |
MEIR1 treanscription regulator |
12 |
0.97 |
chr8_71670686_71670840 | 3.01 |
Unc13a |
unc-13 homolog A |
973 |
0.33 |
chr1_72828894_72829045 | 3.01 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
3647 |
0.27 |
chr14_48120655_48121139 | 3.01 |
Peli2 |
pellino 2 |
25 |
0.97 |
chr15_74955530_74955708 | 3.01 |
Ly6e |
lymphocyte antigen 6 complex, locus E |
34 |
0.94 |
chr14_73143060_73143245 | 2.99 |
Rcbtb2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
5 |
0.98 |
chr10_80818984_80819169 | 2.99 |
Jsrp1 |
junctional sarcoplasmic reticulum protein 1 |
5578 |
0.07 |
chr12_99468179_99468384 | 2.99 |
Foxn3 |
forkhead box N3 |
18184 |
0.18 |
chr8_36248849_36249171 | 2.99 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
506 |
0.81 |
chr15_103323198_103323354 | 2.99 |
Zfp385a |
zinc finger protein 385A |
234 |
0.86 |
chr19_36553654_36554112 | 2.97 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
756 |
0.72 |
chr11_82858816_82858975 | 2.97 |
Rffl |
ring finger and FYVE like domain containing protein |
11849 |
0.1 |
chr6_22355827_22356125 | 2.96 |
Fam3c |
family with sequence similarity 3, member C |
97 |
0.98 |
chr1_155112239_155112390 | 2.94 |
Ier5 |
immediate early response 5 |
12678 |
0.14 |
chr2_119742132_119742303 | 2.93 |
Itpka |
inositol 1,4,5-trisphosphate 3-kinase A |
120 |
0.91 |
chrX_38564990_38565180 | 2.93 |
Cul4b |
cullin 4B |
423 |
0.84 |
chr4_137468902_137469053 | 2.93 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
174 |
0.93 |
chr9_105878487_105878719 | 2.92 |
Col6a5 |
collagen, type VI, alpha 5 |
3203 |
0.27 |
chr9_110333595_110333757 | 2.92 |
Scap |
SREBF chaperone |
40 |
0.96 |
chr10_75932476_75932648 | 2.92 |
Mmp11 |
matrix metallopeptidase 11 |
60 |
0.87 |
chr12_108275433_108275608 | 2.92 |
Ccdc85c |
coiled-coil domain containing 85C |
95 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 13.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
2.6 | 7.7 | GO:0021586 | pons maturation(GO:0021586) |
2.5 | 10.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.4 | 4.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.4 | 11.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.3 | 9.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
2.3 | 6.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.3 | 9.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.2 | 15.5 | GO:0051775 | response to redox state(GO:0051775) |
2.2 | 8.6 | GO:0007296 | vitellogenesis(GO:0007296) |
2.1 | 12.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.1 | 6.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
2.0 | 11.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.9 | 1.9 | GO:0097501 | stress response to metal ion(GO:0097501) |
1.9 | 5.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.9 | 1.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.9 | 7.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.9 | 9.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.9 | 1.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.9 | 5.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.8 | 5.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.8 | 11.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.8 | 5.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.8 | 7.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.8 | 1.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
1.8 | 5.4 | GO:0070384 | Harderian gland development(GO:0070384) |
1.8 | 5.3 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.7 | 1.7 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
1.7 | 5.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.7 | 8.5 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.7 | 6.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.6 | 9.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.6 | 4.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.6 | 4.9 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.6 | 19.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.6 | 8.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
1.6 | 6.4 | GO:0032898 | neurotrophin production(GO:0032898) |
1.6 | 4.8 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.6 | 4.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.6 | 4.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.6 | 4.8 | GO:0008050 | female courtship behavior(GO:0008050) |
1.6 | 6.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.6 | 3.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.5 | 13.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.5 | 3.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.5 | 4.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.5 | 4.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.5 | 4.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.4 | 7.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
1.4 | 4.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.4 | 9.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 4.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.4 | 5.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.4 | 1.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.3 | 2.7 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.3 | 4.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.3 | 2.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.3 | 4.0 | GO:0048840 | otolith development(GO:0048840) |
1.3 | 7.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.3 | 3.9 | GO:0045472 | response to ether(GO:0045472) |
1.3 | 5.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.3 | 3.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.3 | 3.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.3 | 3.8 | GO:0048382 | mesendoderm development(GO:0048382) |
1.3 | 7.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.3 | 2.6 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
1.3 | 1.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.3 | 5.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.2 | 3.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.2 | 6.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.2 | 4.9 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
1.2 | 11.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.2 | 3.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.2 | 3.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.2 | 7.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.2 | 3.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.2 | 3.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.2 | 1.2 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
1.2 | 4.7 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
1.2 | 3.5 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.2 | 4.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.2 | 12.7 | GO:0007097 | nuclear migration(GO:0007097) |
1.2 | 6.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.2 | 3.5 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.2 | 3.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.1 | 3.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.1 | 1.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
1.1 | 5.7 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.1 | 4.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.1 | 2.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 1.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.1 | 2.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 2.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.1 | 5.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.1 | 6.6 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
1.1 | 4.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.1 | 1.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
1.1 | 2.2 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 5.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.1 | 1.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
1.1 | 2.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.0 | 3.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.0 | 3.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 3.1 | GO:0097503 | sialylation(GO:0097503) |
1.0 | 7.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.0 | 4.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.0 | 6.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.0 | 3.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.0 | 1.0 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
1.0 | 2.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.0 | 7.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 1.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.0 | 5.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.0 | 2.0 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.0 | 6.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.0 | 4.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.0 | 4.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.0 | 6.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.0 | 3.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.0 | 3.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.0 | 2.9 | GO:0040031 | snRNA modification(GO:0040031) |
1.0 | 2.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.0 | 2.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.0 | 3.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.0 | 7.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.0 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.0 | 3.9 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
1.0 | 2.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 3.8 | GO:0044849 | estrous cycle(GO:0044849) |
1.0 | 1.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.0 | 3.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.0 | 4.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.0 | 5.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.9 | 3.8 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.9 | 5.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.9 | 2.8 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.9 | 2.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.9 | 2.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.9 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.9 | 2.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.9 | 2.8 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.9 | 1.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.9 | 1.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.9 | 5.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.9 | 4.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.9 | 1.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.9 | 2.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 2.7 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 4.5 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.9 | 1.8 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.9 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 0.9 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.9 | 2.7 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.9 | 2.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.9 | 0.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.9 | 4.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.9 | 2.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.9 | 3.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.9 | 2.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.9 | 1.7 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.9 | 5.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.9 | 5.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.9 | 2.6 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.9 | 1.7 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.9 | 2.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.8 | 4.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.8 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.8 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.8 | 3.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.8 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 4.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.8 | 2.5 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 1.7 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.8 | 2.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 3.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.8 | 0.8 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.8 | 4.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.8 | 2.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 0.8 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.8 | 2.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.8 | 2.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.8 | 1.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.8 | 3.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.8 | 0.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.8 | 8.1 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.8 | 4.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.8 | 2.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.8 | 1.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 0.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.8 | 2.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.8 | 1.6 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.8 | 1.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.8 | 3.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 2.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.8 | 2.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.8 | 10.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.8 | 7.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.8 | 3.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.8 | 1.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.8 | 1.6 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.8 | 2.4 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 3.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.8 | 3.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.8 | 2.4 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.8 | 3.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.8 | 5.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.8 | 2.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.8 | 1.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.8 | 1.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.8 | 2.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 3.1 | GO:0007418 | ventral midline development(GO:0007418) |
0.8 | 4.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.8 | 0.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.8 | 0.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.8 | 6.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.8 | 3.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 9.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.8 | 1.5 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.8 | 3.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.8 | 0.8 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 1.5 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.8 | 6.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.7 | 2.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 4.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 5.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.7 | 3.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.7 | 7.4 | GO:0001553 | luteinization(GO:0001553) |
0.7 | 3.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.7 | 2.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.7 | 4.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.7 | 0.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.7 | 1.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.7 | 2.9 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.7 | 13.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.7 | 2.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.7 | 0.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 5.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.7 | 2.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.7 | 1.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.7 | 2.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.7 | 1.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.7 | 5.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.7 | 5.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.7 | 0.7 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.7 | 7.1 | GO:0046697 | decidualization(GO:0046697) |
0.7 | 2.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 1.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.7 | 1.4 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.7 | 1.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.7 | 7.8 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.7 | 2.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.7 | 0.7 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.7 | 2.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 4.2 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.7 | 2.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.7 | 2.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.7 | 1.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 4.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.7 | 2.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.7 | 5.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 2.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.7 | 6.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 4.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 1.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.7 | 2.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.7 | 1.4 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.7 | 2.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.7 | 2.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.7 | 3.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.7 | 0.7 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.7 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 1.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.7 | 2.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 14.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.7 | 0.7 | GO:0001705 | ectoderm formation(GO:0001705) |
0.7 | 1.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.7 | 2.7 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.7 | 5.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.7 | 2.7 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.7 | 2.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.7 | 3.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 1.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.7 | 2.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 0.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.7 | 2.7 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.7 | 6.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.7 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 0.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.7 | 2.0 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 1.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.7 | 2.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 5.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.7 | 3.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.7 | 5.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.7 | 6.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.7 | 1.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.7 | 2.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.7 | 2.6 | GO:0006983 | ER overload response(GO:0006983) |
0.7 | 3.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 3.3 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.7 | 3.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.7 | 3.3 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.7 | 2.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.7 | 2.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.6 | 1.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.6 | 3.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.6 | 2.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.6 | 3.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.6 | 2.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 3.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 7.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.6 | 1.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 2.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.6 | 2.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.6 | 7.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 2.5 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 1.9 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 1.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.6 | 11.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.6 | 1.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.6 | 4.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 1.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.6 | 1.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 2.5 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 3.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.6 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 1.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.6 | 3.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.6 | 3.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 4.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.6 | 2.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 1.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 3.7 | GO:1901660 | calcium ion export(GO:1901660) |
0.6 | 1.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.6 | 1.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.6 | 5.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 2.4 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.6 | 0.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 3.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.6 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 0.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.6 | 2.4 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.6 | 3.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 2.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.6 | 2.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.6 | 1.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 1.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.6 | 2.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 1.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.6 | 1.8 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.6 | 0.6 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.6 | 1.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.6 | 3.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.6 | 1.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.6 | 2.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.6 | 0.6 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.6 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 3.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 2.3 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.6 | 8.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 7.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 1.7 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.6 | 1.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 1.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.6 | 0.6 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.6 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 1.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.6 | 1.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.6 | 2.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 2.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 2.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 1.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.6 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 3.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.6 | 3.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 2.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.6 | 0.6 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.6 | 5.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.6 | 1.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 5.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.6 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 1.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.5 | 2.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 4.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.5 | 2.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.5 | 1.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.5 | 3.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.5 | 1.1 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 0.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.5 | 2.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 1.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.5 | 2.2 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.5 | 3.8 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 1.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.5 | 1.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 1.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.5 | 1.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.5 | 2.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.5 | 2.7 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.5 | 1.6 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.5 | 4.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 | 1.6 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.5 | 3.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.5 | 2.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 3.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.5 | 1.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 2.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 3.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.5 | 1.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 2.1 | GO:0032329 | serine transport(GO:0032329) |
0.5 | 1.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.5 | 1.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 0.5 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.5 | 1.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 9.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.5 | 2.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.5 | 2.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 1.0 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.5 | 5.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 4.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 3.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 1.5 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.5 | 2.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 1.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 1.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 2.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 0.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.5 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 2.0 | GO:0060430 | lung saccule development(GO:0060430) |
0.5 | 2.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 2.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.5 | 1.0 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.5 | 0.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 1.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 2.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 3.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 3.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 1.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.5 | 2.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 0.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.5 | 2.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 2.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 10.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.5 | 1.5 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.5 | 0.5 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.5 | 1.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 4.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 3.9 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.5 | 1.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.5 | 0.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.5 | 1.9 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.5 | 1.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.5 | 1.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.5 | 0.5 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.5 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.5 | 1.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 1.4 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 1.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.5 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 3.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.5 | 8.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.5 | 10.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 2.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.5 | 0.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 0.5 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.5 | 4.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 0.9 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.5 | 1.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 1.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.5 | 2.3 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.5 | 5.1 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.5 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.5 | 0.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.5 | 2.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 0.9 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.5 | 3.7 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.5 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 1.8 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.5 | 1.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 0.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 0.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.5 | 2.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 5.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 0.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.5 | 2.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 2.3 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 4.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 2.7 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.4 | 1.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 3.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.4 | 3.6 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.4 | 3.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 4.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 0.9 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.4 | 2.7 | GO:0031579 | membrane raft organization(GO:0031579) |
0.4 | 1.3 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.4 | 4.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.4 | 5.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.4 | 4.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 1.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 1.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 2.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.4 | 2.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 2.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 1.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 1.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.4 | 1.3 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.4 | 1.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.4 | 1.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.4 | 2.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 0.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 4.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 1.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 5.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 0.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 2.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 0.4 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.4 | 1.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 11.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.4 | 3.8 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.4 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.4 | 1.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 2.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.4 | 7.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.4 | 0.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.4 | 1.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 0.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 1.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 2.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.4 | 1.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 2.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.4 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 1.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 0.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 1.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 2.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.4 | 9.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.8 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.4 | 3.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.4 | 5.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 0.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.4 | 1.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.4 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 1.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 0.8 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.4 | 3.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.4 | 1.6 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.4 | 2.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.4 | 0.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 4.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.4 | 4.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 1.2 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.4 | 0.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 0.4 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.4 | 1.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 1.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 2.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.4 | 4.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.4 | 9.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 2.8 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.4 | 3.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 1.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.4 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 2.0 | GO:0044321 | response to leptin(GO:0044321) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 0.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 1.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.4 | 1.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 0.8 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 2.3 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.4 | 8.9 | GO:0060323 | head morphogenesis(GO:0060323) |
0.4 | 0.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.4 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 0.8 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.4 | 1.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.4 | 2.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 2.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 2.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 2.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.4 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 1.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 4.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.8 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 1.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 0.8 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.4 | 1.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 0.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 1.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.4 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 2.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 1.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 1.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.4 | 2.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 4.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 4.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 0.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.4 | 8.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.4 | 1.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 1.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.5 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.4 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 1.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.4 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 0.4 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.4 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 2.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 1.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 5.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.4 | 1.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 0.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.4 | 2.2 | GO:0098869 | removal of superoxide radicals(GO:0019430) cellular oxidant detoxification(GO:0098869) |
0.4 | 1.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 0.7 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 1.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 2.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 1.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 4.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 1.8 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 0.7 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.4 | 0.4 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.4 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 1.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.4 | 2.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 4.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.4 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 3.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.4 | 3.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 0.7 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.4 | 1.8 | GO:0035878 | nail development(GO:0035878) |
0.4 | 2.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.4 | 0.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.4 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 2.8 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 1.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 1.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 1.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 1.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 8.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 1.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 1.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 1.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 1.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 1.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 2.0 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 0.3 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.3 | 3.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.3 | 1.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.7 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 3.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 0.7 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 1.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.3 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 2.3 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 3.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.3 | 13.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 3.0 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.3 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 1.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 1.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.3 | 2.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 1.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 1.6 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 2.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.7 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.3 | 1.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 1.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 1.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 3.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 1.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 0.6 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 2.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.3 | 1.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 1.0 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.9 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 1.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.6 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.3 | 2.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 1.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 1.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 2.8 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 6.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 0.6 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.3 | 5.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.3 | 1.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 0.9 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 10.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 3.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 0.6 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 1.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 1.5 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.3 | 0.3 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 2.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.9 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 1.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 4.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 0.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 0.9 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 2.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 0.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 8.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.3 | 2.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.3 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.3 | 3.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.6 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.3 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 2.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 0.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.6 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 2.1 | GO:0060914 | heart formation(GO:0060914) |
0.3 | 0.9 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.3 | 2.7 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.3 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 1.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 5.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 0.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 3.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 1.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 3.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 0.3 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.3 | 1.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 1.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 0.9 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.3 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.3 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.1 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 2.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 2.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 0.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 1.7 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.3 | 1.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 1.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.3 | 0.3 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.3 | 1.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 1.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 5.3 | GO:0050802 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.3 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 2.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 0.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 4.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.3 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 0.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 0.3 | GO:1900222 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 1.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 0.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 1.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 0.5 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 0.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 1.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 1.6 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 1.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 3.0 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 1.6 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 2.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 1.9 | GO:0060746 | parental behavior(GO:0060746) |
0.3 | 2.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 1.3 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 5.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 0.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 1.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 2.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 1.6 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 15.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 2.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 1.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.3 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 1.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 1.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 0.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.5 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 1.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 1.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.7 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.2 | 0.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 1.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 3.2 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 2.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 4.2 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 4.4 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.0 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.2 | 1.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 1.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 3.9 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.2 | 0.5 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) |
0.2 | 1.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 1.4 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 1.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.5 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 2.3 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 0.2 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 1.4 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.5 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.2 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 1.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.2 | 0.5 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.2 | 3.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 1.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.2 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.2 | 1.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 2.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 7.2 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 0.9 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.2 | 3.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 9.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.2 | 0.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 1.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 1.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.6 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.7 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.9 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 2.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 1.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.4 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.4 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.2 | 0.7 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.2 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.9 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 1.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 2.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.2 | 1.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 1.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 1.3 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.2 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.2 | GO:0072683 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.2 | 1.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 0.4 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.2 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.6 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.2 | GO:0048241 | epinephrine transport(GO:0048241) |
0.2 | 3.4 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.9 | GO:0035904 | aorta development(GO:0035904) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.8 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.2 | 0.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 4.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 1.8 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.2 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.2 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 0.6 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.2 | 0.2 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 1.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 1.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.2 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.2 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 3.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 1.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 2.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.4 | GO:0006901 | vesicle coating(GO:0006901) |
0.2 | 1.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 1.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.2 | 2.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 2.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 2.6 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.2 | 1.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.0 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.2 | 0.2 | GO:0010324 | membrane invagination(GO:0010324) |
0.2 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.4 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.2 | 0.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.6 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 1.0 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.4 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.2 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.6 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 1.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 1.4 | GO:0030728 | ovulation(GO:0030728) |
0.2 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 1.5 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.8 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 0.2 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
0.2 | 0.2 | GO:0001660 | fever generation(GO:0001660) |
0.2 | 2.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 1.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.2 | GO:1990182 | exosomal secretion(GO:1990182) |
0.2 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 2.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.4 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.2 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.2 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.2 | 1.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 6.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.7 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 0.9 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 1.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.4 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.2 | 0.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 0.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.2 | 0.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.8 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.2 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 6.9 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 2.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 0.4 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.2 | 0.4 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 2.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.4 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 0.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 2.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.2 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.6 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.2 | 0.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.5 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 0.3 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 1.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 4.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 3.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 5.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 2.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 0.7 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.5 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.2 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.8 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 1.5 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 0.2 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.2 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.8 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.2 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.2 | 0.2 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 1.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 2.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 2.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.4 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 2.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.2 | 3.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 2.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.2 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 4.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.9 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 3.3 | GO:2000181 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
0.2 | 0.3 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 1.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.0 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 1.2 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 5.3 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.4 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 1.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 3.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.6 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 1.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.6 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 1.7 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 1.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 2.7 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 0.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.7 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 1.0 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 2.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.7 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 1.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 1.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 1.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.6 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 2.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 1.6 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.9 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.1 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 2.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.8 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 1.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 1.0 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.1 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 1.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.7 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.9 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 2.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 3.7 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.8 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.4 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.4 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 2.4 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 1.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.6 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 2.3 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 0.1 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.1 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.8 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 1.4 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.3 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 3.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 10.1 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.1 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.1 | 0.8 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
0.1 | 0.4 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 3.8 | GO:0021510 | spinal cord development(GO:0021510) |
0.1 | 0.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.1 | 0.1 | GO:0043090 | amino acid import(GO:0043090) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 1.9 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.6 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.1 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.4 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.5 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0001736 | establishment of planar polarity(GO:0001736) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 1.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 1.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 1.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 2.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.3 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 1.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 1.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.3 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.1 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 0.2 | GO:0045078 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.4 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.5 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 1.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 3.0 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.1 | 0.7 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.7 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.1 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 1.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.2 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 1.2 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 1.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.1 | GO:0045117 | azole transport(GO:0045117) |
0.1 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0003272 | endocardial cushion formation(GO:0003272) |
0.1 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.3 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.9 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
0.1 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 1.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 2.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 1.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:0032608 | interferon-beta production(GO:0032608) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 1.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.1 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.4 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.1 | 0.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 1.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.1 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 1.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.3 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.1 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.2 | GO:0009620 | response to fungus(GO:0009620) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 1.1 | GO:0045981 | positive regulation of nucleotide metabolic process(GO:0045981) positive regulation of purine nucleotide metabolic process(GO:1900544) |
0.1 | 0.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.3 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.0 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.0 | 0.2 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.8 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 1.0 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.0 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 1.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.0 | 2.7 | GO:0050953 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.0 | 0.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.9 | GO:1990138 | neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.0 | 0.0 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.1 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.4 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.0 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.0 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.0 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 0.2 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.6 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.0 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.0 | 0.5 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 1.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.4 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.0 | 0.1 | GO:1900372 | negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.0 | 0.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.0 | 0.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.0 | GO:0032637 | interleukin-8 production(GO:0032637) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.1 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0003208 | cardiac ventricle morphogenesis(GO:0003208) |
0.0 | 0.0 | GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) regulation of isotype switching(GO:0045191) |
0.0 | 0.0 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.0 | 0.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.2 | 11.1 | GO:0008091 | spectrin(GO:0008091) |
2.2 | 6.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 6.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.6 | 4.8 | GO:0097443 | sorting endosome(GO:0097443) |
1.5 | 1.5 | GO:0097513 | myosin II filament(GO:0097513) |
1.4 | 4.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.3 | 7.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.2 | 3.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.2 | 3.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.2 | 1.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.2 | 5.8 | GO:0000805 | X chromosome(GO:0000805) |
1.1 | 10.2 | GO:0000124 | SAGA complex(GO:0000124) |
1.1 | 4.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.0 | 5.2 | GO:0070695 | FHF complex(GO:0070695) |
1.0 | 4.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.0 | 3.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.0 | 2.0 | GO:0032437 | cuticular plate(GO:0032437) |
1.0 | 3.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.0 | 4.0 | GO:0000322 | storage vacuole(GO:0000322) |
1.0 | 3.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.0 | 10.0 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 3.0 | GO:0035061 | interchromatin granule(GO:0035061) |
1.0 | 5.8 | GO:0043219 | lateral loop(GO:0043219) |
1.0 | 4.8 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 2.8 | GO:0097413 | Lewy body(GO:0097413) |
0.9 | 8.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 2.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.9 | 2.7 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.9 | 2.6 | GO:0031523 | Myb complex(GO:0031523) |
0.9 | 1.7 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 3.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 1.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 3.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.8 | 0.8 | GO:0012505 | endomembrane system(GO:0012505) |
0.8 | 5.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.8 | 8.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.8 | 9.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.8 | 2.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 2.4 | GO:0000811 | GINS complex(GO:0000811) |
0.8 | 3.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.8 | 4.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.8 | 2.3 | GO:0036396 | MIS complex(GO:0036396) |
0.8 | 3.1 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 4.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.8 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 5.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 4.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 3.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.8 | 3.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 3.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.7 | 4.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.7 | 10.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.7 | 2.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 5.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.7 | 4.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.7 | 2.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.7 | 2.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 2.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 2.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.7 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.7 | 1.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.7 | 2.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 2.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 3.4 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 5.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 3.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 2.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 3.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 2.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 5.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 18.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.6 | 1.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.6 | 2.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 5.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 1.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.6 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 40.5 | GO:0016605 | PML body(GO:0016605) |
0.6 | 1.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 1.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.6 | 3.0 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 12.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.6 | 24.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 7.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 1.8 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 4.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 1.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 2.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.6 | 6.4 | GO:0043218 | compact myelin(GO:0043218) |
0.6 | 5.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 8.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.6 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.6 | 2.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.5 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 1.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 21.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 5.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.5 | 4.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 2.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 7.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 0.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 4.1 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 2.0 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 9.5 | GO:0043034 | costamere(GO:0043034) |
0.5 | 4.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 10.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.5 | 1.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 3.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.5 | 2.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 2.9 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 11.7 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 3.9 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 2.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.5 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.5 | 1.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.5 | 2.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 4.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 3.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 9.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 2.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 4.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.5 | 2.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 3.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 10.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 8.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.4 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 2.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 1.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 13.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 1.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 0.4 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 1.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.4 | 2.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 2.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 3.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 2.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 4.1 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 0.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.4 | 2.4 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 4.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 2.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 3.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 1.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.4 | 3.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 1.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 1.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 3.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 1.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 3.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 4.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 1.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 16.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 9.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 0.4 | GO:0005818 | aster(GO:0005818) |
0.4 | 1.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 3.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 10.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 1.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 0.4 | GO:0044297 | cell body(GO:0044297) |
0.4 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 1.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.4 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 0.7 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 3.3 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 2.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 2.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 3.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 3.9 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 2.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 8.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.4 | 3.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 1.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 34.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.4 | 2.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 2.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 5.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 2.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 13.7 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 2.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 8.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 3.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 6.6 | GO:0044298 | cell body membrane(GO:0044298) |
0.3 | 4.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 3.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 15.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.3 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 16.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.3 | 1.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 1.9 | GO:0000801 | central element(GO:0000801) |
0.3 | 4.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 1.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 5.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 3.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 10.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 3.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 18.6 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 7.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 1.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 1.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 82.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 2.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 1.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 2.9 | GO:0042383 | sarcolemma(GO:0042383) |
0.3 | 2.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 23.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 2.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 6.2 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 3.3 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 3.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 4.2 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.3 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 12.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 0.3 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.3 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 5.1 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 4.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 4.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 2.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.3 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 5.3 | GO:0005770 | late endosome(GO:0005770) |
0.3 | 5.0 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 2.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 0.5 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.3 | 2.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 6.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.3 | 1.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.3 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 9.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 4.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.3 | 1.3 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 4.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 12.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 2.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 2.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.7 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 1.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.7 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 18.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.2 | GO:0042995 | cell projection(GO:0042995) |
0.2 | 1.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 3.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 6.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 3.4 | GO:0005901 | caveola(GO:0005901) |
0.2 | 2.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 20.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 20.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 1.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 2.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 4.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 1.0 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 2.1 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 2.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 2.0 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 3.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 5.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 5.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 21.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 1.0 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 16.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.8 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 0.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 0.7 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.5 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.4 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 0.4 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.4 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 3.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 12.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 3.0 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.7 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 14.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 38.9 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.2 | 1.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 3.0 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 0.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 5.6 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.8 | GO:0031256 | leading edge membrane(GO:0031256) |
0.2 | 2.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 2.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 4.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 11.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.2 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 106.5 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.2 | 2.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 21.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 16.2 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.9 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 5.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 14.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 10.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 6.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 3.5 | GO:0005903 | brush border(GO:0005903) |
0.1 | 5.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.9 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 3.7 | GO:0005844 | polysome(GO:0005844) |
0.1 | 4.0 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 0.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 2.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 17.3 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 3.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.3 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 42.9 | GO:0031410 | cytoplasmic vesicle(GO:0031410) intracellular vesicle(GO:0097708) |
0.1 | 18.7 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 9.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 8.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 147.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 2.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 5.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 7.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 5.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 56.0 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 0.7 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 48.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 3.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 11.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 444.5 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 125.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.5 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.4 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.7 | GO:0043234 | protein complex(GO:0043234) |
0.0 | 25.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 5.5 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.0 | GO:0071944 | cell periphery(GO:0071944) |
0.0 | 0.1 | GO:0009986 | cell surface(GO:0009986) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.9 | 8.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.5 | 7.4 | GO:1990188 | euchromatin binding(GO:1990188) |
2.5 | 2.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.8 | 12.9 | GO:0008494 | translation activator activity(GO:0008494) |
1.8 | 5.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.8 | 12.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.8 | 5.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.7 | 11.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.6 | 1.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.6 | 4.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.6 | 4.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.4 | 1.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.4 | 7.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.4 | 16.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.4 | 11.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 17.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.3 | 3.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.3 | 3.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.2 | 3.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.2 | 4.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.2 | 10.8 | GO:0031386 | protein tag(GO:0031386) |
1.2 | 4.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.2 | 7.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.2 | 12.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.2 | 11.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.1 | 1.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.1 | 5.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.1 | 1.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
1.1 | 3.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 3.3 | GO:0004359 | glutaminase activity(GO:0004359) |
1.1 | 4.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.1 | 3.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.1 | 3.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.1 | 4.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 4.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.1 | 9.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.1 | 3.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 4.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.0 | 7.3 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.0 | 3.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.0 | 5.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.0 | 5.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.0 | 6.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.0 | 5.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.0 | 6.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.0 | 3.0 | GO:2001070 | starch binding(GO:2001070) |
1.0 | 2.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 7.1 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 3.0 | GO:0070905 | serine binding(GO:0070905) |
1.0 | 4.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.0 | 7.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.0 | 4.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.0 | 3.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.0 | 3.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.0 | 3.0 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.0 | 7.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.0 | 2.0 | GO:0050692 | DBD domain binding(GO:0050692) |
1.0 | 1.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.0 | 4.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.0 | 10.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.9 | 0.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.9 | 3.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.9 | 4.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 4.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.9 | 9.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.9 | 2.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.9 | 2.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.9 | 2.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.9 | 8.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 7.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.9 | 2.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.9 | 0.9 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.9 | 1.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.9 | 2.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.9 | 3.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 8.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 2.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.8 | 2.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.8 | 2.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.8 | 0.8 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.8 | 5.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 2.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 2.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 13.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.8 | 10.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.8 | 2.4 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.8 | 1.6 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.8 | 10.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.8 | 4.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 4.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 3.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 3.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.8 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 1.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 1.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.8 | 1.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.8 | 1.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.8 | 2.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 4.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.8 | 2.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 0.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.7 | 2.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 2.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.7 | 2.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 20.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.7 | 8.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 5.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.7 | 2.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.7 | 2.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 2.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 8.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 7.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.7 | 2.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 5.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.7 | 14.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 1.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.7 | 2.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.7 | 7.7 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.7 | 3.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 0.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.7 | 4.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 2.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 8.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.7 | 2.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 4.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 7.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 3.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.7 | 5.9 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.7 | 2.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.7 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.7 | 2.6 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.6 | 3.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 3.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.6 | 1.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 4.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.6 | 2.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 1.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.6 | 6.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.6 | 6.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.6 | 1.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 0.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 9.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 1.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 1.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 4.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 4.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 13.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 3.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.6 | 0.6 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.6 | 1.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.6 | 3.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 1.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.6 | 6.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 1.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.6 | 0.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.6 | 0.6 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 1.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.6 | 6.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 1.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 4.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.6 | 1.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.6 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.6 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 9.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.6 | 1.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 7.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.6 | 2.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.6 | 2.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.6 | 2.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 1.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 2.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 1.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 2.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 4.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 2.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.5 | 1.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 2.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 1.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.5 | 2.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 10.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 2.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 6.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 1.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 6.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.5 | 1.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 2.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 3.1 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 5.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 4.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.5 | 2.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 4.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 2.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 14.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 9.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.5 | 3.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.5 | 11.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 2.0 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 2.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 2.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 2.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 2.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.5 | 5.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 3.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 1.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 2.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 24.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 4.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 3.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 1.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 2.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 1.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 2.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 1.0 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.5 | 1.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 4.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 2.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 3.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 1.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 15.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 1.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 1.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 0.9 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 4.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 1.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.4 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 1.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 5.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 1.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.5 | 1.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 4.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.5 | 2.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.4 | 5.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 40.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 1.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 3.1 | GO:0034560 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.4 | 5.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.4 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.4 | 5.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 9.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.4 | 2.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 28.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 2.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 3.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.7 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 2.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 13.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.4 | 2.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 0.8 | GO:0008948 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) oxaloacetate decarboxylase activity(GO:0008948) |
0.4 | 3.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 2.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.6 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 1.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 2.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 4.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 30.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.4 | 5.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 2.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 3.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 3.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 1.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 2.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 5.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 6.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 7.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 4.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 1.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 2.6 | GO:0052687 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.4 | 3.7 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.4 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 3.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 1.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 3.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 7.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.7 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 1.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 5.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 0.7 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 1.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 6.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 0.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.4 | 1.8 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.4 | 1.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 3.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 1.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 0.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 1.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 2.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 1.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 4.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 4.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 1.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.3 | 2.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 7.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 2.4 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 7.8 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 3.1 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 2.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 1.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 1.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 0.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 2.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 1.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 10.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 3.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 4.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 2.0 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 3.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 3.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 5.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 8.6 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.3 | 1.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 1.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 2.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 1.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 2.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 9.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 0.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 0.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 3.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 3.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 11.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 3.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 3.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 8.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 0.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 7.9 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.3 | 2.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 8.7 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.3 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 1.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 11.3 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.3 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 0.9 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 42.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 3.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 0.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 0.9 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 0.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 3.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 15.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 0.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 1.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 0.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 2.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 3.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 1.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 0.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 3.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 2.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 1.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 2.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 3.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 1.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 2.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.3 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 3.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 3.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 2.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 3.0 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 2.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.3 | 1.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 3.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 2.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 2.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 6.7 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 6.2 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 6.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 1.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 1.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 7.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 1.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 7.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
0.2 | 26.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.9 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 2.3 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.2 | 0.9 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 5.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 4.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 4.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 6.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 14.2 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 0.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.2 | 10.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 9.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 8.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 3.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 0.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 6.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.6 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 5.7 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.2 | 10.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 2.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 2.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 2.0 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 1.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 1.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 17.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 5.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 2.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 5.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 1.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 3.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 1.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 2.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 2.4 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 1.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 1.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 1.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 1.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 23.5 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 20.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 9.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 1.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.2 | 0.5 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 2.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 0.3 | GO:0031267 | small GTPase binding(GO:0031267) |
0.2 | 1.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 2.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 8.5 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.2 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 3.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 3.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.2 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 5.3 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 8.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 0.7 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 1.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 1.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 17.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 2.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 2.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.2 | GO:0097617 | annealing activity(GO:0097617) |
0.2 | 2.9 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 2.9 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 13.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 4.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 60.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.7 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 2.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 2.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 7.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 12.0 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 4.5 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 4.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 3.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.8 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 3.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 4.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 2.5 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 5.7 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 6.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 2.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 10.9 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 1.5 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 1.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 1.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.8 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 14.5 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 5.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 13.6 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 1.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 80.7 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 4.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 2.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 2.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cGMP activated cation channel activity(GO:0005223) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 2.6 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 3.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.8 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.5 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 3.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 31.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 4.3 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 3.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0033293 | monocarboxylic acid binding(GO:0033293) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 1.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.1 | 1.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 2.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 1.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 1.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 21.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.2 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 6.6 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 2.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 2.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 5.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 6.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 2.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.6 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 1.4 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 2.6 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 6.2 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 1.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.7 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 5.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 1.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.6 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 5.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 1.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.5 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.0 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 2.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 7.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.8 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 2.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.1 | 24.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.0 | 8.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 1.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.8 | 13.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.8 | 16.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.8 | 12.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.8 | 3.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.8 | 7.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.8 | 2.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 13.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.7 | 22.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.7 | 14.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 4.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.7 | 2.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 18.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 14.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 3.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 8.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 3.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 8.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 32.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 2.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 8.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 17.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 8.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 9.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 18.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 9.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 8.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 1.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 2.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 3.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 11.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.5 | 29.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 5.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 18.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.5 | 1.4 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 9.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 8.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 14.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 5.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 13.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 12.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 2.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 4.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 3.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 5.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 2.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 1.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 29.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 2.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 1.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 9.7 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 13.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 4.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 13.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 11.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 1.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 2.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 4.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 6.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 3.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 7.2 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 7.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 10.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 2.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 4.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 2.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 3.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 4.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 9.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 7.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 48.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 3.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 6.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 1.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 3.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 4.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 8.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 5.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 1.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 6.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 5.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 3.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 4.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 3.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 1.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.2 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 2.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.3 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 6.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 6.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 7.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.7 | 8.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.3 | 12.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.3 | 15.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.3 | 9.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.1 | 11.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.1 | 11.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
1.1 | 2.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.0 | 9.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 14.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.0 | 13.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.0 | 17.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 1.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.9 | 7.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 19.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 13.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.8 | 7.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.8 | 0.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.7 | 3.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.7 | 7.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.7 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.7 | 16.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 6.8 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.7 | 5.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.7 | 13.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 4.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 7.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.6 | 2.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 3.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.6 | 17.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 19.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.6 | 4.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 9.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 8.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 3.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.6 | 8.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 11.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 8.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 1.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 1.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.5 | 13.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 6.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 2.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 2.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 5.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 4.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 19.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 7.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 8.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 0.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.5 | 5.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 6.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 3.8 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.5 | 10.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 9.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.5 | 5.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.5 | 8.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 5.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 4.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 15.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 3.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 1.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.4 | 3.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 4.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 5.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 5.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 8.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 3.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 7.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 5.7 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.4 | 2.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 5.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 7.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 1.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 3.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 11.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 7.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 6.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 10.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 5.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 5.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 2.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 33.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 0.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 6.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 2.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 2.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 8.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 3.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 5.8 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.3 | 2.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 0.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 7.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 12.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 2.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 4.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 1.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 0.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 1.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 3.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 1.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 1.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.3 | 4.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 20.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 2.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 3.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 2.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 2.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 2.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 42.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 17.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 1.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 3.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 3.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 8.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 3.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 6.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 7.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 2.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 1.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 6.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.2 | 3.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 5.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 1.3 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.2 | 2.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 0.9 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 1.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 1.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 6.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 1.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 1.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.4 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 3.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 5.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.9 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 7.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 7.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 5.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 2.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 2.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 7.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.7 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.8 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 3.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 1.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.1 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 2.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.2 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.3 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.0 | 0.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |